anurajms/meta_analysis huggingface dataset:
comparison group:
Dipeptidyl‐peptidase (DPP)‐4 inhibitors and glucagon‐like peptide (GLP)‐1 analogues for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk for the development of type 2 diabetes mellitus
1. Nutrition Therapy 2. Blood Glucose Lowering Drugs, Excl. Insulins 3. Placebo 4. Physical therapy exercises
comparison group:
Lifestyle interventions for the treatment of women with gestational diabetes
1. Expectant Management 2. Usual Care
comparison group:
Supportive interventions for enhancing dietary intake in malnourished or nutritionally at‐risk adults
1. Usual Care
comparison group:
Drug interventions for the treatment of obesity in children and adolescents
1. Placebo 2. Usual Care
comparison group:
Insulin secretagogues for prevention or delay of type 2 diabetes mellitus and its associated complications in persons at increased risk for the development of type 2 diabetes mellitus
1. Placebo 2. Other Drugs Used In Diabetes 3. Glycaemic-lowering agent
comparison group:
Short‐acting insulin analogues versus regular human insulin for adults with type 1 diabetes mellitus
1. Insulin
comparison group:
Fortification of staple foods with zinc for improving zinc status and other health outcomes in the general population
1. Micronutrients 2. Foods
comparison group:
Continuous subcutaneous insulin infusion versus multiple daily injections of insulin for pregnant women with diabetes
1. Insulins and analogues
comparison group:
Autologous platelet‐rich plasma for treating chronic wounds
1. Placebo 2. Usual Care 3. Protease Modulating Matrix Treatment
comparison group:
Different intensities of glycaemic control for pregnant women with pre‐existing diabetes
1. Blood Glucose Monitoring
comparison group:
Self management interventions for type 2 diabetes in adult people with severe mental illness
1. Usual Care
comparison group:
Sodium‐glucose cotransporter (SGLT) 2 inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at risk for the development of type 2 diabetes mellitus
1. Blood Glucose Lowering Drugs, Excl. Insulins
comparison group:
Radioiodine therapy versus antithyroid medications for Graves' disease
1. Antithyroid Preparation
comparison group:
Skin grafting and tissue replacement for treating foot ulcers in people with diabetes
1. Placebo 2. Skin Grafting 3. Usual Care
comparison group:
Subcutaneous rapid‐acting insulin analogues for diabetic ketoacidosis
1. Intravenous 2. Insulins and analogues
comparison group:
Intensive versus conventional glycaemic control for treating diabetic foot ulcers
1. Usual Care
comparison group:
Parent‐only interventions for childhood overweight or obesity in children aged 5 to 11 years
1. Parent 2. Usual Care
comparison group:
Thyroid surgery for Graves’ disease and Graves’ ophthalmopathy
1. Thyroidectomy
comparison group:
Growth factors for treating diabetic foot ulcers
1. Placebo 2. Usual Care
comparison group:
Aromatase inhibitors for short stature in male children and adolescents
1. Androgens 2. Placebo
comparison group:
Systemic antibiotics for treating diabetic foot infections
1. Antibacterials For Systemic Use 2. Placebo 3. Usual Care
comparison group:
Complex interventions for preventing diabetic foot ulceration
1. Diabetic Care 2. Usual Care
comparison group:
Total or near‐total thyroidectomy versus subtotal thyroidectomy for multinodular non‐toxic goitre in adults
1. Subtotal Thyroidectomy
comparison group:
Hyperbaric oxygen therapy for chronic wounds
1. Usual Care
comparison group:
Topical non‐steroidal anti‐inflammatory agents for diabetic cystoid macular oedema
1. Placebo
comparison group:
Calcimimetics for secondary hyperparathyroidism in chronic kidney disease patients
1. Pharmacotherapy 2. Placebo
comparison group:
Intensive glucose control versus conventional glucose control for type 1 diabetes mellitus
1. Conventional Glucose Control
comparison group:
Transtheoretical model stages of change for dietary and physical exercise modification in weight loss management for overweight and obese adults
1. Usual Care 2. Physical Therapy Education
comparison group:
Vitamin D supplementation for prevention of mortality in adults
1. Placebo
comparison group:
Blue‐light filtering spectacle lenses for visual performance, sleep, and macular health in adults
1. Eye Glasses
comparison group:
Laser‐assisted cataract surgery versus standard ultrasound phacoemulsification cataract surgery
1. Phacoemulsification
comparison group:
Antibiotics versus placebo for acute bacterial conjunctivitis
1. Placebo
comparison group:
Device‐modified trabeculectomy for glaucoma
1. Trabeculectomy 2. Trabeculectomy With Intraoperative Application Of Mitomycin 3. Glaucoma Shunt Device 4. Amniotic Membrane Graft To Cornea
comparison group:
Lens extraction versus laser peripheral iridotomy for acute primary angle closure
1. Laser Iridotomy
comparison group:
Interventions for acute non‐arteritic central retinal artery occlusion
1. Sham Intervention 2. Placebo
comparison group:
Trifocal intraocular lenses versus bifocal intraocular lenses after cataract extraction among participants with presbyopia
1. Bifocal intraocular device
comparison group:
Iridotomy to slow progression of visual field loss in angle‐closure glaucoma
1. Sham Intervention
comparison group:
Early vitrectomy for exogenous endophthalmitis following surgery
1. Follow-up Consultation 2. Vitrectomy 3. Intravitreal Antibiotic Injection
comparison group:
Adjunctive steroid therapy versus antibiotics alone for acute endophthalmitis after intraocular procedure
1. Antibiotic Therapy
comparison group:
Tocilizumab for giant cell arteritis
1. Corticosteroids - Opthamological and Otological
comparison group:
Immediate sequential bilateral surgery versus delayed sequential bilateral surgery for cataracts
1. Phacoemulsification 2. Delayed surgery 3. Intraocular lens
comparison group:
Topical pharmacologic interventions versus placebo for epidemic keratoconjunctivitis
1. Placebo 2. Usual Care
comparison group:
Pneumatic retinopexy versus scleral buckle for repairing simple rhegmatogenous retinal detachments
1. Scleral Buckling With Vitrectomy 2. Scleral Buckle
comparison group:
Fornix‐based versus limbal‐based conjunctival trabeculectomy flaps for glaucoma
1. Trabeculectomy 2. Trabeculectomy With Intraoperative Application Of Antimetabolite
comparison group:
Intraocular lens optic edge design for the prevention of posterior capsule opacification after cataract surgery
1. Insertion Of Intraocular Lens
comparison group:
Adjunctive modulation of wound healing during cataract surgery to promote survival of a previous trabeculectomy
1. Mitomycin 2. Monoclonal Antibodies 3. Phacoemulsification 4. Radiotherapy 5. Fluorouracil
comparison group:
Photobiomodulation for non‐exudative age‐related macular degeneration
1. Placebo
comparison group:
Surgery for idiopathic epiretinal membrane
1. Sham Intervention
comparison group:
Lens extraction for chronic angle‐closure glaucoma
1. Trabeculectomy 2. Iridotomy 3. Laser Iridoplasty 4. Lysis Of Goniosynechiae 5. Antiglaucoma Preparations And Miotics
comparison group:
Laser peripheral iridoplasty for chronic angle closure
1. Travoprost Ophthalmic Solution 2. Laser Iridotomy
comparison group:
Ab interno trabecular bypass surgery with Trabectome for open‐angle glaucoma
1. Trabeculectomy 2. Minimal Invasive Glaucoma Surgery 3. Glaucoma Shunt Device 4. Argon Laser Trabeculoplasty 5. Selective Laser Trabeculoplasty 6. Phacoemulsification
comparison group:
Wavefront excimer laser refractive surgery for adults with refractive errors
1. Wavefront-optimized refractive surgery 2. Refractive Surgery
comparison group:
Visual cycle modulators versus placebo or observation for the prevention and treatment of geographic atrophy due to age‐related macular degeneration
1. Placebo
comparison group:
Corneal collagen cross‐linking for bacterial infectious keratitis
1. Cefazolin 2. Amikacin 3. Amphotericin B 4. Gentamicin 5. Doxycycline 6. Vancomycin 7. Ceftazidime 8. Itraconazole
comparison group:
Treatment regimens for administration of anti‐vascular endothelial growth factor agents for neovascular age‐related macular degeneration
1. Ranibizumab 2. Aflibercept 3. Pro re nata 4. Bevacizumab
comparison group:
Laser‐assisted in‐situ keratomileusis (LASIK) with a mechanical microkeratome compared to LASIK with a femtosecond laser for LASIK in adults with myopia or myopic astigmatism
1. Laser Assisted In Situ Keratomileusis 2. Femtosecond Pulsed Laser
comparison group:
Intense pulsed light (IPL) therapy for the treatment of meibomian gland dysfunction
1. Skin-soothing Wipe 2. Sham Intervention 3. Artificial tears 4. Manual Expression Of Sebaceous Gland 5. Placebo
comparison group:
Ab interno trabecular bypass surgery with Schlemm´s canal microstent (Hydrus) for open angle glaucoma
1. Trabeculectomy 2. Minimal Invasive Glaucoma Surgery 3. Phacoemulsification 4. Selective Laser Trabeculoplasty 5. Argon Laser Trabeculoplasty
comparison group:
Low vision rehabilitation for better quality of life in visually impaired adults
1. Waiting list control
comparison group:
Toric intraocular lens versus limbal relaxing incisions for corneal astigmatism after phacoemulsification
1. Limbal Relaxing Incision
comparison group:
Pars plana vitrectomy combined with scleral buckle versus pars plana vitrectomy for giant retinal tear
1. Scleral Buckle
comparison group:
Topical cyclosporine A therapy for dry eye syndrome
1. Artificial tears 2. Placebo
comparison group:
Conventional occlusion versus pharmacologic penalization for amblyopia
1. Atropine Penalization Therapy
comparison group:
Intrastromal corneal ring segments for treating keratoconus
1. Contact Lenses 2. Eye Glasses
comparison group:
Aqueous shunts with mitomycin C versus aqueous shunts alone for glaucoma
1. Glaucoma Shunt Device
comparison group:
Ab interno trabecular bypass surgery with iStent for open‐angle glaucoma
1. Trabeculectomy 2. Minimal Invasive Glaucoma Surgery 3. Phacoemulsification 4. Selective Laser Trabeculoplasty 5. Argon Laser Trabeculoplasty
comparison group:
Cyclodestructive procedures for refractory glaucoma
1. Glaucoma Shunt Device 2. Transcleral Diode Laser Cycloablation
comparison group:
Pars plana vitrectomy versus scleral buckling for repairing simple rhegmatogenous retinal detachments
1. Scleral Buckle
comparison group:
Endoscopic cyclophotocoagulation (ECP) for open angle glaucoma and primary angle closure
1. Trabeculectomy 2. Minimal Invasive Glaucoma Surgery 3. Photocoagulation Of Ciliary Body 4. Argon Laser Trabeculoplasty 5. Selective Laser Trabeculoplasty 6. Phacoemulsification
comparison group:
Routine preoperative medical testing for cataract surgery
1. Usual Care
comparison group:
Anti‐tumour necrosis factor biological therapies for the treatment of uveitic macular oedema (UMO) for non‐infectious uveitis
1. Tumor Necrosis Factor Alpha Inhibitors 2. Placebo
comparison group:
Subconjunctival draining minimally‐invasive glaucoma devices for medically uncontrolled glaucoma
1. Trabeculectomy 2. Minimal Invasive Glaucoma Surgery 3. Selective Laser Trabeculoplasty 4. Argon Laser Trabeculoplasty 5. Phacoemulsification
comparison group:
Descemet's membrane endothelial keratoplasty (DMEK) versus Descemet's stripping automated endothelial keratoplasty (DSAEK) for corneal endothelial failure
1. Descemet's Stripping Endothelial Keratoplasty
comparison group:
Blue‐light filtering intraocular lenses (IOLs) for protecting macular health
1. Insertion Of Intraocular Lens
comparison group:
Reading aids for adults with low vision
1. Low Vision Aid 2. Optical Low Vision Aid Provision
comparison group:
Optical correction of refractive error for preventing and treating eye symptoms in computer users
1. Sham Intervention
comparison group:
Adjustable versus non‐adjustable sutures for strabismus
1. Strabismus Surgery
comparison group:
Interventions to increase attendance for diabetic retinopathy screening
1. Diabetic Retinopathy Screening 2. Usual Care
comparison group:
Anti‐vascular endothelial growth factor (VEGF) drugs for treatment of retinopathy of prematurity
1. Laser Photocoagulation To Retina 2. Cryotherapy To Retina
comparison group:
Surgical interventions for vertical strabismus in superior oblique palsy
1. Operations On Superior Oblique
comparison group:
Interventions to improve access to cataract surgical services and their impact on equity in low‐ and middle‐income countries
1. Usual Care
comparison group:
Ocriplasmin for symptomatic vitreomacular adhesion
1. Sham Intervention 2. Placebo
comparison group:
Different‐sized incisions for phacoemulsification in age‐related cataract
1. Bimanual Microincisional Phacoemulsification Of Cataract With Intraocular Lens Implantation
comparison group:
Aqueous shunts for glaucoma
1. Trabeculectomy 2. Glaucoma Shunt Device 3. Usual Care
comparison group:
Probing for congenital nasolacrimal duct obstruction
1. Massage Of Body Region 2. Antibiotics, Ophthalmologic
comparison group:
Non‐steroidal anti‐inflammatory drugs versus corticosteroids for controlling inflammation after uncomplicated cataract surgery
1. Corticosteroids - Otological 2. Topical
comparison group:
Nd:YAG laser vitreolysis versus pars plana vitrectomy for vitreous floaters
1. Vitrectomy
comparison group:
Topical non‐steroidal anti‐inflammatory drugs for analgesia in traumatic corneal abrasions
1. Artificial tears 2. Mydriatics And Cycloplegics 3. Analgesics 4. Applying Medication To Eyes 5. Curative 6. Eye Patch 7. Antibiotics For Topical Use
comparison group:
Autologous serum eye drops for dry eye
1. Artificial tears 2. Placebo 3. Saline
comparison group:
N‐acetylcarnosine (NAC) drops for age‐related cataract
1. Artificial tears 2. Applying Medication To Eyes 3. Curative 4. Saline 5. Cataract Surgery
comparison group:
Endonasal versus external dacryocystorhinostomy for nasolacrimal duct obstruction
1. Dacryocystorhinostomy
comparison group:
Perioperative medications for preventing temporarily increased intraocular pressure after laser trabeculoplasty
1. Trabeculotomy 2. Antiglaucoma Preparations And Miotics
comparison group:
Topical medication instillation techniques for glaucoma
1. Usual Care
comparison group:
Surgery for cataracts in people with age‐related macular degeneration
1. Extraction Of Cataract 2. Delayed Treatment
comparison group:
Laser‐assisted subepithelial keratectomy (LASEK) versus laser‐assisted in‐situ keratomileusis (LASIK) for correcting myopia
1. Laser Assisted In Situ Keratomileusis
comparison group:
Perioperative antibiotics for prevention of acute endophthalmitis after cataract surgery
1. Antibacterials For Systemic Use 2. Prophylaxis
comparison group:
Non‐surgical interventions for acute internal hordeolum
1. Hot/cold Therapy Pack/compression Therapy System
comparison group:
Anti‐vascular endothelial growth factor for choroidal neovascularisation in people with pathological myopia
1. Sham Intervention 2. Laser Photocoagulation To Retina 3. Antineovascularisation Agents 4. Photodynamic Therapy
comparison group:
Multifocal versus monofocal intraocular lenses after cataract extraction
1. Insertion Of Intraocular Lens
comparison group:
Fibrin glue versus sutures for conjunctival autografting in primary pterygium surgery
1. Surgical Suture 2. Conjunctival Autograft To Conjunctiva
comparison group:
Oral antivirals for preventing recurrent herpes simplex keratitis in people with corneal grafts
1. Placebo
comparison group:
Valacyclovir versus acyclovir for the treatment of herpes zoster ophthalmicus in immunocompetent patients
1. Aciclovir
comparison group:
Integrated versus non‐integrated orbital implants for treating anophthalmic sockets
1. Orbital Implant
comparison group:
Prophylactic non‐steroidal anti‐inflammatory drugs for the prevention of macular oedema after cataract surgery
1. Corticosteroids - Otological
comparison group:
Statins for age‐related macular degeneration
1. Placebo 2. Statin Prophylaxis
comparison group:
Patching for corneal abrasion
1. Antibiotics For Topical Use
comparison group:
Antibiotics versus no treatment for toxoplasma retinochoroiditis
1. Placebo
comparison group:
Over the counter (OTC) artificial tear drops for dry eye syndrome
1. Artificial tears 2. Placebo
comparison group:
Laser‐assisted subepithelial keratectomy (LASEK) versus photorefractive keratectomy (PRK) for correction of myopia
1. Wavefront-guided Photorefractive Keratectomy
comparison group:
Peripheral iridotomy for pigmentary glaucoma
1. Surgery 2. Drug Therapy
comparison group:
Conjunctival autograft for pterygium
1. Amniotic Membrane Graft To Cornea
comparison group:
Aflibercept for neovascular age‐related macular degeneration
1. Sham Intervention 2. Ranibizumab 3. Bevacizumab
comparison group:
Doxycycline plus ivermectin versus ivermectin alone for treatment of patients with onchocerciasis
1. Ivermectin
comparison group:
Anti‐vascular endothelial growth factor for control of wound healing in glaucoma surgery
1. Interpersonal Intervention 2. Corticosteroids - Otological 3. Antineovascularisation Agents
comparison group:
Interventions for dissociated vertical deviation
1. Strabismus Surgery 2. Non-Surgical Interventions
comparison group:
Interventions for trachoma trichiasis
1. Correction Of Trichiasis By Incision Of Lid Margin
comparison group:
Mitomycin C versus 5‐Fluorouracil for wound healing in glaucoma surgery
1. Postoperative 2. Trabeculectomy With Intraoperative Application Of 5-fluorouracil 3. Fluorouracil
comparison group:
Day care versus in‐patient surgery for age‐related cataract
1. Inpatient Care
comparison group:
Laser treatment of drusen to prevent progression to advanced age‐related macular degeneration
1. Sham Intervention
comparison group:
Intravitreal steroids versus observation for macular edema secondary to central retinal vein occlusion
1. Sham Intervention 2. Placebo
comparison group:
Sub‐Tenon's anaesthesia versus topical anaesthesia for cataract surgery
1. Topical Local Anesthetic To Eye 2. Anesthesia For Lens Surgery
comparison group:
Immunosuppressants for the prophylaxis of corneal graft rejection after penetrating keratoplasty
1. Immunosuppressant 2. Corticosteroids - Otological 3. Placebo
comparison group:
Corticosteroids for treating optic neuritis
1. Sham Intervention 2. Corticosteroids - Otological 3. Placebo
comparison group:
Interventions for idiopathic intracranial hypertension
1. Placebo
comparison group:
Combined surgery versus cataract surgery alone for eyes with cataract and glaucoma
1. Phacoemulsification
comparison group:
Assistive technology for children and young people with low vision
1. Low Vision Aid 2. Optical Low Vision Aid Provision
comparison group:
Macular grid laser photocoagulation for branch retinal vein occlusion
1. Sham Intervention 2. Vitrectomy 3. Intravitreal Steroid Injection 4. Antineovascularisation Agents
comparison group:
Medical interventions for fungal keratitis
1. Surgical Superficial Keratectomy 2. Antibiotics, Ophthalmologic
comparison group:
Surgery for nonarteritic anterior ischemic optic neuropathy
1. Follow-up Ophthalmological Assessment 2. Usual Care
comparison group:
Optical reading aids for children and young people with low vision
1. Low Vision Aid 2. Optical Low Vision Aid Provision
comparison group:
Medical interventions for acanthamoeba keratitis
1. Biguanides - Antimalarial
comparison group:
Face washing promotion for preventing active trachoma
1. Antibacterials For Systemic Use
comparison group:
Antiviral treatment and other therapeutic interventions for herpes simplex virus epithelial keratitis
1. Antivirals
comparison group:
Interventions for asymptomatic retinal breaks and lattice degeneration for preventing retinal detachment
1. Laser Photocoagulation To Retina 2. Cryotherapy
comparison group:
Excimer laser refractive surgery versus phakic intraocular lenses for the correction of moderate to high myopia
1. Implantation Of Phakic Intraocular Lens Implant
comparison group:
D‐Penicillamine for preventing retinopathy of prematurity in preterm infants
1. Placebo
comparison group:
Vitamin D for the treatment of inflammatory bowel disease
1. Vitamin D 2. Placebo 3. Low Dose
comparison group:
Fibrin‐based haemostatic agents for reducing blood loss in adult liver resection
1. Non-bioabsorbable Hemostatic Agent 2. Placebo
comparison group:
Prostaglandins for adult liver transplanted recipients
1. Placebo 2. Usual Care
comparison group:
Expanded polytetrafluoroethylene (ePTFE)‐covered stents versus bare stents for transjugular intrahepatic portosystemic shunt in people with liver cirrhosis
1. Stent
comparison group:
Rifaximin for prevention and treatment of hepatic encephalopathy in people with cirrhosis
1. Lactulose 2. Lactitol 3. Placebo
comparison group:
Fibrin sealants for the prevention of postoperative pancreatic fistula following pancreatic surgery
1. Fibrin Glue 2. Placebo
comparison group:
Granulocyte colony‐stimulating factor with or without stem or progenitor cell or growth factors infusion for people with compensated or decompensated advanced chronic liver disease
1. Placebo
comparison group:
Exercise interventions for adults after liver transplantation
1. Sham Intervention 2. Usual Care
comparison group:
Remote care through telehealth for people with inflammatory bowel disease
1. Face-to-face communication 2. Telemedicine
comparison group:
Patient education interventions for the management of inflammatory bowel disease
1. Symptom Management 2. Usual Care
comparison group:
Erythromycin prior to endoscopy for acute upper gastrointestinal haemorrhage
1. Nasogastric Tube 2. Placebo 3. Erythromycin 4. Endoscopy 5. Prokinetic Agent
comparison group:
Interventions to improve sanitation for preventing diarrhoea
1. Usual Care
comparison group:
Fundoplication in laparoscopic Heller's cardiomyotomy for achalasia
1. Fundoplication 2. Heller Cardiomyotomy
comparison group:
Treatment of enteric fever (typhoid and paratyphoid fever) with cephalosporins
1. Cephalosporins
comparison group:
Electromagnetic‐guided versus endoscopic‐guided postpyloric placement of nasoenteral feeding tubes
1. Endoscopic-guided post-pyloric placement
comparison group:
Certolizumab pegol for maintenance of medically induced remission in Crohn’s disease
1. Placebo
comparison group:
Physical activity for treatment of irritable bowel syndrome
1. Exercise 2. Physical activity 3. Usual Care
comparison group:
Antibiotics for uncomplicated diverticulitis
1. Placebo 2. Antibiotic Therapy
comparison group:
Stem cell transplantation for induction of remission in medically refractory Crohn’s disease
1. Placebo 2. Usual Care
comparison group:
Tacrolimus (FK506) for induction of remission in corticosteroid‐refractory ulcerative colitis
1. Pharmacotherapy 2. Placebo
comparison group:
Guidewire‐assisted cannulation of the common bile duct for the prevention of post‐endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis
1. Sphincterotome 2. Catheter 3. Endoscopic Retrograde Cholangiopancreatography
comparison group:
Proton pump inhibitor treatment initiated prior to endoscopic diagnosis in upper gastrointestinal bleeding
1. Histamine H2 antagonist
comparison group:
Intraperitoneal local anaesthetic instillation versus no intraperitoneal local anaesthetic instillation for laparoscopic cholecystectomy
1. Placebo
comparison group:
Mesh fixation techniques in primary ventral or incisional hernia repair
1. Hernia Surgical Mesh 2. Repair Of Ventral Hernia Using Sutures 3. Fibrin Glue 4. Tack
comparison group:
Primary prevention of variceal bleeding in people with oesophageal varices due to liver cirrhosis: a network meta‐analysis
1. Beta Blocking Agent 2. Transjugular Intrahepatic Portosystemic Shunt 3. Portosystemic Shunt Operation 4. Endoscopy Of Upper Gastrointestinal Tract And Banding Of Varix Of Esophagus 5. Organic Nitrates 6. Sclerotherapy Of Esophageal Varices
comparison group:
Secondary prevention of variceal bleeding in adults with previous oesophageal variceal bleeding due to decompensated liver cirrhosis: a network meta‐analysis
1. Transjugular Intrahepatic Portosystemic Shunt 2. Portosystemic Shunt Operation 3. Endoscopy Of Upper Gastrointestinal Tract And Banding Of Varix Of Esophagus 4. Organic Nitrates 5. Beta Blocking Agents, Non-selective 6. Sclerotherapy Of Esophageal Varices
comparison group:
Risk of postoperative infectious complications from medical therapies in inflammatory bowel disease
1. Drug Therapy 2. Placebo
comparison group:
Portosystemic shunts versus endoscopic intervention with or without medical treatment for prevention of rebleeding in people with cirrhosis
1. Fiberoptic Esophagoscopy And Banding Of Esophageal Varices 2. Sclerotherapy Of Esophageal Varices
comparison group:
Interventions for preventing postpartum constipation
1. Usual Care
comparison group:
Adalimumab for maintenance of remission in Crohn's disease
1. Placebo
comparison group:
Antibiotic prophylaxis for prevention of postoperative wound infection in adults undergoing open elective inguinal or femoral hernia repair
1. Antibiotic Therapy
comparison group:
Nasogastric versus nasojejunal tube feeding for severe acute pancreatitis
1. Nasojejunal Feeding
comparison group:
Anti‐IL‐12/23p40 antibodies for maintenance of remission in Crohn's disease
1. Placebo
comparison group:
Adalimumab for induction of remission in Crohn's disease
1. Placebo
comparison group:
Band ligation versus beta‐blockers for primary prophylaxis of oesophageal variceal bleeding in children with chronic liver disease or portal vein thrombosis
1. Beta Blocking Agent
comparison group:
Certolizumab pegol for induction of remission in Crohn's disease
1. Placebo
comparison group:
Plasma expanders for people with cirrhosis and large ascites treated with abdominal paracentesis
1. Plasma expander 2. Placebo
comparison group:
Lateral pararectal versus transrectal stoma placement for prevention of parastomal herniation
1. Preventive 2. Transrectal stoma placement
comparison group:
Adjuvant therapy with antidepressants for the management of inflammatory bowel disease
1. Placebo 2. Usual Care
comparison group:
Glucocorticosteroids for people with alcoholic hepatitis
1. Placebo
comparison group:
N‐acetylcysteine as an adjuvant therapy for Helicobacter pylori eradication
1. Antibacterials For Systemic Use
comparison group:
Antibiotics for induction and maintenance of remission in Crohn's disease
1. Placebo
comparison group:
Acetyl‐L‐carnitine for patients with hepatic encephalopathy
1. Placebo
comparison group:
Cannabis for the treatment of ulcerative colitis
1. Placebo
comparison group:
Surgical portosystemic shunts versus transjugular intrahepatic portosystemic shunt for variceal haemorrhage in people with cirrhosis
1. Transjugular Intrahepatic Portosystemic Shunt
comparison group:
Swallowing therapy for dysphagia in acute and subacute stroke
1. Sham Intervention 2. Usual Care
comparison group:
Carvedilol versus traditional, non‐selective beta‐blockers for adults with cirrhosis and gastroesophageal varices
1. Nadolol 2. Propranolol
comparison group:
Prokinetics for functional dyspepsia
1. Cisapride 2. Mosapride 3. Domperidone 4. Placebo 5. Metoclopramide
comparison group:
Modifying the consistency of food and fluids for swallowing difficulties in dementia
1. Usual Care
comparison group:
Mesh versus non‐mesh for inguinal and femoral hernia repair
1. Primary Repair Of Inguinal Hernia Using Sutures 2. Primary Repair Of Femoral Hernia Using Sutures
comparison group:
Epidural analgesia versus patient‐controlled intravenous analgesia for pain following intra‐abdominal surgery in adults
1. Patient Controlled Epidural Analgesia 2. Continuous Lumbar Epidural Analgesia
comparison group:
Surgical portosystemic shunts versus devascularisation procedures for prevention of variceal rebleeding in people with hepatosplenic schistosomiasis
1. Devascularization Of Stomach
comparison group:
Prosthetic mesh placement for the prevention of parastomal herniation
1. Usual Care
comparison group:
Glucocorticosteroids for infants with biliary atresia following Kasai portoenterostomy
1. Placebo 2. Usual Care
comparison group:
Withdrawal of immunosuppressant or biologic therapy for patients with quiescent Crohn's disease
1. Usual Care
comparison group:
Interventions for paracetamol (acetaminophen) overdose
1. Activated Charcoal 2. Ipecacuanha 3. Intravenous 4. Placebo 5. Acetylcysteine 6. Curative 7. Irrigation Of Stomach 8. Oral 9. Antidote
comparison group:
Feed thickener for infants up to six months of age with gastro‐oesophageal reflux
1. Placebo
comparison group:
Laparoscopic versus open resection for sigmoid diverticulitis
1. Sigmoid Colectomy
comparison group:
Proton pump inhibitors for functional dyspepsia
1. H2-receptor Antagonists 2. Placebo 3. Prokinetic Agent
comparison group:
Closure methods of the appendix stump for complications during laparoscopic appendectomy
1. Ligation 2. Closure By Clip 3. Closure By Staple
comparison group:
Mesalamine (5‐ASA) for the prevention of recurrent diverticulitis
1. Placebo
comparison group:
Needle syringe programmes and opioid substitution therapy for preventing hepatitis C transmission in people who inject drugs
1. Opiate Substitution Therapy 2. Needle-Exchange Program
comparison group:
Direct‐acting antivirals for chronic hepatitis C
1. Medical Therapy 2. Placebo
comparison group:
Ursodeoxycholic acid for cystic fibrosis‐related liver disease
1. Placebo 2. Usual Care
comparison group:
Flumazenil versus placebo or no intervention for people with cirrhosis and hepatic encephalopathy
1. Placebo
comparison group:
Terlipressin versus placebo or no intervention for people with cirrhosis and hepatorenal syndrome
1. Placebo
comparison group:
Management for intussusception in children
1. Contrast Media 2. Delayed Treatment 3. Diagnostic Imaging Equipment 4. Oral 5. Enemas 6. Following Protocol
comparison group:
Oral calorie supplements for cystic fibrosis
1. Usual Care
comparison group:
Antimicrobial agents for preventing peritonitis in peritoneal dialysis patients
1. Preventive 2. Antimicrobials 3. Placebo
comparison group:
Maintenance immunosuppression for adults undergoing liver transplantation: a network meta‐analysis
1. Immunosuppressive Therapy
comparison group:
Deprescribing versus continuation of chronic proton pump inhibitor use in adults
1. Usual Care
comparison group:
Antibiotic treatment for Clostridium difficile‐associated diarrhoea in adults
1. Antibacterials For Systemic Use 2. Placebo
comparison group:
Hepatitis B immunoglobulin during pregnancy for prevention of mother‐to‐child transmission of hepatitis B virus
1. Placebo
comparison group:
Mesh fixation with glue versus suture for chronic pain and recurrence in Lichtenstein inguinal hernioplasty
1. Tissue Adhesives 2. Suture
comparison group:
Polymer‐based oral rehydration solution for treating acute watery diarrhoea
1. Rehydration Therapy 2. Oral 3. Glucose
comparison group:
Anti‐IL‐12/23p40 antibodies for induction of remission in Crohn's disease
1. Placebo 2. Usual Care
comparison group:
Methods to decrease blood loss during liver resection: a network meta‐analysis
1. Usual Care
comparison group:
Heated insufflation with or without humidification for laparoscopic abdominal surgery
1. Insufflation Gas Conditioning System
comparison group:
Oral 5‐aminosalicylic acid for maintenance of medically‐induced remission in Crohn's disease
1. Placebo 2. Sulfasalazine
comparison group:
Internal dressings for healing perianal abscess cavities
1. Application Of Topical Agent To Skin 2. Closed Drainage Wound Care 3. Packing Of Wound
comparison group:
Osmotic and stimulant laxatives for the management of childhood constipation
1. Drugs For Constipation 2. Placebo
comparison group:
Anti‐tuberculous therapy for maintenance of remission in Crohn's disease
1. Placebo
comparison group:
Epidural local anaesthetics versus opioid‐based analgesic regimens for postoperative gastrointestinal paralysis, vomiting and pain after abdominal surgery
1. Postoperative 2. Epidural 3. Opioids 4. Systemic
comparison group:
Aminosalicylates for induction of remission or response in Crohn's disease
1. Corticosteroids - Opthamological and Otological 2. Placebo 3. Aminosalicylic Acid And Similar Agents
comparison group:
Sequential versus standard triple first‐line therapy for Helicobacter pylori eradication
1. Clarithromycin 2. Amoxicillin 3. Oral 4. Proton pump inhibitor
comparison group:
Booster dose vaccination for preventing hepatitis B
1. Placebo
comparison group:
Fasting for haemostasis in children with gastrointestinal bleeding
1. Usual Care 2. Feeding Regime
comparison group:
Pancreatic duct guidewire placement for biliary cannulation for the prevention of post‐endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis
1. Usual Care
comparison group:
Non‐absorbable disaccharides versus placebo/no intervention and lactulose versus lactitol for the prevention and treatment of hepatic encephalopathy in people with cirrhosis
1. Lactulose 2. Lactitol 3. Placebo
comparison group:
Eradication therapy for peptic ulcer disease in Helicobacter pylori‐positive people
1. Sucralfate 2. Proton Pump Inhibitors 3. H2-receptor Antagonists 4. Placebo 5. Bismuth 6. Antacid
comparison group:
Interventions for necrotising pancreatitis
1. Usual Care
comparison group:
Perioperative dexmedetomidine for acute pain after abdominal surgery in adults
1. Perioperative 2. Placebo
comparison group:
Interventions for dysphagia in long‐term, progressive muscle disease
1. Placebo 2. Usual Care
comparison group:
Glutamine for induction of remission in Crohn's disease
1. Placebo
comparison group:
Periodontal therapy as adjunctive treatment for gastric Helicobacter pylori infection
1. Helicobacter Eradication Therapy
comparison group:
Duodenum‐preserving pancreatic resection versus pancreaticoduodenectomy for chronic pancreatitis
1. Pancreaticoduodenectomy
comparison group:
Pregabalin for decreasing pancreatic pain in chronic pancreatitis
1. Placebo
comparison group:
Enhanced recovery protocols for major upper gastrointestinal, liver and pancreatic surgery
1. Usual Care
comparison group:
Antibiotic prophylaxis for surgical site infection in people undergoing liver transplantation
1. Preventive 2. Parenteral 3. Placebo 4. Antibiotic Prophylaxis
comparison group:
Etrolizumab for induction of remission in ulcerative colitis
1. Placebo
comparison group:
Surgery for complete (full‐thickness) rectal prolapse in adults
1. Diathermy - Surgical 2. Perineal Operations For Rectal Prolapse 3. Insertion Of Encircling Suture Around Anal Sphincter 4. Mesh Rectopexy 5. Transabdominal Rectal Mobilization 6. Repair Of Rectal Prolapse 7. Sponge Rectopexy 8. Partial Resection Of Colon 9. Surgical Suture
comparison group:
Treatment for dysphagia (swallowing difficulties) in hereditary ataxia
1. Therapeutic Procedure 2. Placebo 3. Usual Care
comparison group:
Laparoscopic fundoplication surgery versus medical management for gastro‐oesophageal reflux disease (GORD) in adults
1. Medical Therapy
comparison group:
Azathioprine or 6‐mercaptopurine for maintenance of remission in Crohn's disease
1. Placebo
comparison group:
Oral budesonide for induction of remission in ulcerative colitis
1. Placebo
comparison group:
Noninvasive positive pressure ventilation for acute respiratory failure following upper abdominal surgery
1. Oxygen Therapy
comparison group:
Preoperative inspiratory muscle training for postoperative pulmonary complications in adults undergoing cardiac and major abdominal surgery
1. Usual Care
comparison group:
Interventions for heartburn in pregnancy
1. Sucralfate 2. Histamine H2 Receptor Antagonist Prophylaxis 3. Proton Pump Inhibitors 4. Lifestyle education 5. Drugs For Acid Related Disorders 6. Diet Education 7. Placebo 8. Usual Care 9. Antacid 10. Regimes And Therapies
comparison group:
Type I interferons for induction of remission in ulcerative colitis
1. Interferon Beta Natural 2. Placebo 3. Interferon Alfa
comparison group:
Methotrexate for maintenance of remission in ulcerative colitis
1. Placebo
comparison group:
Unfractionated or low‐molecular weight heparin for induction of remission in ulcerative colitis
1. Placebo 2. Usual Care
comparison group:
Post‐pyloric versus gastric tube feeding for preventing pneumonia and improving nutritional outcomes in critically ill adults
1. Nasogastric Feeding
comparison group:
Plugs for containing faecal incontinence
1. Pelvic Floor Exercises 2. Incontinence Pants, Single-use 3. Drug Therapy 4. Incontinence Appliance 5. Implantation Of Artificial Sphincter In Anorectum 6. Implantation Of Sacral Nerve Stimulator 7. Repair Of Anal Sphincter 8. Insertion Of Dynamic Graciloplasty Sphincter 9. Adult Nappy 10. Incontinence Pants, Reusable 11. Diet Education 12. Incontinence Pants Liner 13. Anal Plug 14. Electromyographic Biofeedback 15. Absorbent Underpad, Non-sterile
comparison group:
Antifibrinolytic amino acids for upper gastrointestinal bleeding in people with acute or chronic liver disease
1. Placebo
comparison group:
Budesonide for induction of remission in Crohn's disease
1. Placebo
comparison group:
Water infusion versus air insufflation for colonoscopy
1. Colonoscopy 2. Insufflation
comparison group:
Endoscopic injection of cyanoacrylate glue versus other endoscopic procedures for acute bleeding gastric varices in people with portal hypertension
1. Ligation 2. Injection Of Sclerosing Agent 3. Sclerotherapy Of Gastric Varices
comparison group:
Enteral nutrition formulations for acute pancreatitis
1. Enteral nutrition 2. Placebo
comparison group:
Endoscopic or surgical intervention for painful obstructive chronic pancreatitis
1. Conservative Therapy
comparison group:
Treatment for cryoglobulinemic and non‐cryoglobulinemic peripheral neuropathy associated with hepatitis C virus infection
1. Placebo
comparison group:
Tranexamic acid for upper gastrointestinal bleeding
1. Placebo
comparison group:
Hepatitis B vaccination during pregnancy for preventing infant infection
1. Placebo 2. Usual Care
comparison group:
Tolerability of selective cyclooxygenase 2 inhibitors used for the treatment of rheumatological manifestations of inflammatory bowel disease
1. Placebo
comparison group:
Non‐nutritive sucking for gastro‐oesophageal reflux disease in preterm and low birth weight infants
1. Placebo
comparison group:
Epinephrine injection versus epinephrine injection and a second endoscopic method in high‐risk bleeding ulcers
1. Epinephrine 2. Injection 3. Endoscopy
comparison group:
Interventions for treating postpartum constipation
1. Placebo
comparison group:
Budesonide for maintenance of remission in Crohn's disease
1. Budesonide 2. Placebo
comparison group:
Vedolizumab for induction and maintenance of remission in ulcerative colitis
1. Placebo
comparison group:
Methotrexate for induction of remission in refractory Crohn's disease
1. Placebo
comparison group:
Antimicrobial drugs for treating cholera
1. Antimicrobials 2. Placebo
comparison group:
Antimicrobial prophylaxis for colorectal surgery
1. Placebo
comparison group:
Botulinum toxin for upper oesophageal sphincter dysfunction in neurological swallowing disorders
1. Placebo 2. Usual Care
comparison group:
Dopamine agents for hepatic encephalopathy
1. Placebo
comparison group:
Early versus delayed laparoscopic cholecystectomy for acute gallstone pancreatitis
1. Delayed Treatment 2. Laparoscopic Cholecystectomy
comparison group:
Abdominal lift for laparoscopic cholecystectomy
1. Surgical Pneumoperitoneum
comparison group:
Opioids for acute pancreatitis pain
1. Analgesics 2. Opioids
comparison group:
Laparoscopic repair for perforated peptic ulcer disease
1. Open Surgical Procedure
comparison group:
Open Mesh versus non‐Mesh for groin hernia repair
1. Open Repair Of Inguinal Hernia 2. Inguinal Herniorrhaphy Using Darn 3. Inguinal Herniorrhaphy Using Synthetic Patch 4. Repair Of Inguinal Hernia Using Synthetic Plug 5. Bassini Repair Of Inguinal Hernia
comparison group:
Antioxidant supplementation for sickle cell disease
1. Antioxidants 2. Placebo
comparison group:
Nebuliser systems for drug delivery in cystic fibrosis
1. Colistin 2. Dornase Alfa 3. Jet Ventilation Device 4. Hypertonic saline 5. Tobramycin
comparison group:
Interventions for improving adherence to airway clearance treatment and exercise in people with cystic fibrosis
1. Usual Care
comparison group:
Digital technology for delivering and monitoring exercise programs for people with cystic fibrosis
1. Usual Care
comparison group:
Interventions for the long‐term prevention of hereditary angioedema attacks
1. Placebo
comparison group:
Strategies for screening for familial hypercholesterolaemia in primary care and other community settings
1. Usual Care
comparison group:
Embolisation for pulmonary arteriovenous malformation
1. Excision Of Arteriovenous Malformation 2. Percutaneous Transluminal Arterial And Venous Embolisation Of Arteriovenous Malformation
comparison group:
Long‐acting inhaled bronchodilators for cystic fibrosis
1. Selective Beta-2-adrenoreceptor Agonists- Inhaled 2. Inhaled Bronchodilator Therapy 3. Placebo 4. Muscarinic Antagonists 5. Usual Care 6. Inhaled
comparison group:
Enzyme replacement therapy for infantile‐onset Pompe disease
1. Enzymes for alimentary tract and metabolism 2. Placebo
comparison group:
Beta‐blockers for preventing aortic dissection in Marfan syndrome
1. Surveillance 2. Placebo
comparison group:
Prophylactic levosimendan for the prevention of low cardiac output syndrome and mortality in paediatric patients undergoing surgery for congenital heart disease
1. Placebo 2. Inotropic agent
comparison group:
Non‐invasive ventilation for cystic fibrosis
1. Usual Care
comparison group:
Non‐surgical interventions for treating heavy menstrual bleeding (menorrhagia) in women with bleeding disorders
1. Desmopressin 2. Mefenamic Acid 3. Blood Coagulation Factors 4. Etamsylate 5. Placebo 6. Progestogens And Estrogen Systemic Contraceptives, Fixed Combinations 7. Tranexamic Acid 8. Progesterone
comparison group:
Pneumococcal vaccines for cystic fibrosis
1. Placebo
comparison group:
Intravenous alpha‐1 antitrypsin augmentation therapy for treating patients with alpha‐1 antitrypsin deficiency and lung disease
1. Placebo 2. Usual Care
comparison group:
Enzyme replacement therapy for Anderson‐Fabry disease
1. Enzymes for alimentary tract and metabolism 2. Placebo 3. Usual Care
comparison group:
Palivizumab for prophylaxis against respiratory syncytial virus infection in children with cystic fibrosis
1. Prophylaxis 2. Placebo
comparison group:
Topical cystic fibrosis transmembrane conductance regulator gene replacement for cystic fibrosis‐related lung disease
1. Gene Therapy 2. Placebo
comparison group:
Neuraminidase inhibitors for the treatment of influenza infection in people with cystic fibrosis
1. Antivirals 2. Placebo
comparison group:
Enzyme replacement therapy with idursulfase for mucopolysaccharidosis type II (Hunter syndrome)
1. Placebo 2. Usual Care
comparison group:
Anti‐inflammatory drugs and analgesics for managing symptoms in people with cystic fibrosis‐related arthritis
1. Non-steroidal Anti-inflammatory Drug 2. Analgesics 3. Placebo
comparison group:
Home versus hospital intravenous antibiotic therapy for cystic fibrosis
1. Hospital 2. Antibiotic Therapy
comparison group:
Ascorbic acid for the treatment of Charcot‐Marie‐Tooth disease
1. Placebo
comparison group:
Oral steroids for long‐term use in cystic fibrosis
1. Placebo 2. Usual Care
comparison group:
Vaccines for preventing infection with Pseudomonas aeruginosa in cystic fibrosis
1. Preventive 2. Pseudomonas Vaccines 3. Placebo 4. Vaccine
comparison group:
Intravenous antibiotics for pulmonary exacerbations in people with cystic fibrosis
1. Intravenous 2. Placebo 3. Oral 4. Nebulizer 5. Antibiotic Therapy
comparison group:
Prophylactic milrinone for the prevention of low cardiac output syndrome and mortality in children undergoing surgery for congenital heart disease
1. Placebo 2. Inotropic agent 3. Other Cardiac Stimulants 4. Nitric Oxide 5. Vasopressins
comparison group:
Surgical interventions for treating pectus excavatum
1. Procedure To Costal Cartilage
comparison group:
Sodium channel blockers for cystic fibrosis
1. Sodium Channnel Blockers
comparison group:
Vaccines for preventing influenza in people with cystic fibrosis
1. Influenza Virus Vaccine 2. Placebo
comparison group:
Interventions for promoting physical activity in people with cystic fibrosis
1. Placebo 2. Usual Care
comparison group:
Nebulized and oral thiol derivatives for pulmonary disease in cystic fibrosis
1. Placebo 2. Drug Therapy
comparison group:
Single‐incision sling operations for urinary incontinence in women
1. Urinary Incontinence/sling Operation 2. Laparoscopic Colposuspension 3. Single Incision Mid-urethral Mini-sling 4. Colposuspension
comparison group:
Surgical approach to hysterectomy for benign gynaecological disease
1. Laparoscopic Hysterectomy 2. Vaginal Hysterectomy 3. Abdominal Hysterectomy 4. Laparoscopic Total Hysterectomy Using Robotic Assistance
comparison group:
Combined oral contraceptive pill for primary dysmenorrhoea
1. Non-steroidal Anti-inflammatory Drug 2. Placebo 3. Combined Oral Contraceptive Pill
comparison group:
Surgery for women with apical vaginal prolapse
1. Sacrohysteropexy 2. Repair Of Urinary Stress Incontinence 3. Repair Of Vault Of Vagina With Mesh Using Vaginal Approach 4. Surgical Repair Of Prolapsed Uterus 5. Abdominal Hysterectomy 6. Vaginal 7. Abdominal Sacrocolpopexy 8. Hysterectomy 9. Pelvic Organ Prolapse Surgical Mesh 10. Sacrospinous Fixation Of Vaginal Vault
comparison group:
Statins for women with polycystic ovary syndrome not actively trying to conceive
1. Placebo
comparison group:
Gonadotropin‐releasing hormone analogues for endometriosis
1. Calcium-regulating agents 2. Analgesics 3. Add-back therapy 4. Gestrinone 5. Placebo 6. Intrauterine Administration 7. Progesterone 8. Oral 9. Injection 10. Luteinizing Hormone-releasing Hormone Agonist 11. Danazol
comparison group:
Oral anticholinergic drugs versus placebo or no treatment for managing overactive bladder syndrome in adults
1. Placebo
comparison group:
Immediate versus delayed postpartum insertion of contraceptive implant and IUD for contraception
1. Insertion of intrauterine contraceptive device
comparison group:
Hormone therapy for uterine and endometrial development in women with premature ovarian insufficiency
1. Oestrogen therapy 2. Placebo 3. Progesterone
comparison group:
Interventions to prevent or treat heavy menstrual bleeding or pain associated with intrauterine‐device use
1. Non-steroidal Anti-inflammatory Drug 2. Desmopressin 3. Placebo 4. Tranexamic Acid
comparison group:
Medical methods for first trimester abortion
1. Prostaglandins 2. Mifepristone 3. Tamoxifen 4. Misoprostol
comparison group:
Immediate versus delayed postabortal insertion of contraceptive implant
1. Contraceptive implant
comparison group:
Treatment for recurrent vulvovaginal candidiasis (thrush)
1. Gentian Violet 2. Probiotics 3. Cider Vinegar 4. Antifungals For Systemic Use 5. Vaccination 6. Placebo 7. Antifungals For Topical Use 8. Tea Tree Oil 9. Garlic 10. Vaginal douche 11. Boric Acid
comparison group:
Surgical interventions for the management of chronic pelvic pain in women
1. Pelvic adhesiolysis 2. Sham Intervention 3. Microlaparoscopy 4. Hysterectomy 5. Uterosacral ligament resection 6. Salpingo-oophorectomy 7. Oophorectomy 8. Endoscopic Suspension Of Uterus 9. Conscious pain-mapping laparoscopy 10. Open Ventrosuspension Of Uterus 11. Diagnostic Laparoscopy 12. Pelvic vein ligation 13. Laparoscopic Uterosacral Nerve Ablation
comparison group:
Levonorgestrel‐releasing intrauterine device (LNG‐IUD) for symptomatic endometriosis following surgery
1. Placebo
comparison group:
Ultrasound‐guided transvaginal ovarian needle drilling for clomiphene‐resistant polycystic ovarian syndrome in subfertile women
1. Ovulation Induction 2. Endoscopic Drilling Of Ovary 3. Gonadotropins
comparison group:
Pentoxifylline for the treatment of endometriosis‐associated pain and infertility  
1. Surgery 2. Placebo
comparison group:
Medical abortion offered in pharmacy versus clinic‐based settings
1. Pharmacy 2. Medical abortion
comparison group:
Selective oestrogen receptor modulators (SERMs) for endometriosis
1. Placebo
comparison group:
Dopamine agonists for preventing ovarian hyperstimulation syndrome
1. Placebo 2. Usual Care
comparison group:
Metformin treatment before and during IVF or ICSI in women with polycystic ovary syndrome
1. Placebo
comparison group:
Progestogens or progestogen‐releasing intrauterine systems for uterine fibroids (other than preoperative medical therapy)
1. Surgery 2. Medical Therapy 3. Placebo